FI115032B - Förfarande för att behandla ryggsjukdom - Google Patents

Förfarande för att behandla ryggsjukdom Download PDF

Info

Publication number
FI115032B
FI115032B FI20002229A FI20002229A FI115032B FI 115032 B FI115032 B FI 115032B FI 20002229 A FI20002229 A FI 20002229A FI 20002229 A FI20002229 A FI 20002229A FI 115032 B FI115032 B FI 115032B
Authority
FI
Finland
Prior art keywords
disease
pain
men
back pain
lower back
Prior art date
Application number
FI20002229A
Other languages
English (en)
Finnish (fi)
Other versions
FI20002229A (sv
FI20002229A0 (sv
Inventor
Teuvo Sihvonen
Timo Lakka
Jukka T Salonen
Original Assignee
Teuvo Sihvonen
Jurilab Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teuvo Sihvonen, Jurilab Ltd Oy filed Critical Teuvo Sihvonen
Priority to FI20002229A priority Critical patent/FI115032B/sv
Publication of FI20002229A0 publication Critical patent/FI20002229A0/sv
Publication of FI20002229A publication Critical patent/FI20002229A/sv
Application granted granted Critical
Publication of FI115032B publication Critical patent/FI115032B/sv

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (2)

11c05?
1. Användning av en betablockare eller en nitrat för framställning av en farmaceu-tisk komposition for att behandla och/eller förhindra icke-specifik ryggsjukdom, osteartrit och andra degenerativa muskuloskeletala sjukdomar.
1. Beta-salpaajan tai nitraatin käyttö farmaseuttisen koostumuksen valmistamiseksi epäspesifisen selkäsairauden, nivelrikon ja muiden degeneratii-visten tuki-ja liikuntaelinsairauksien hoitamiseksi ja/tai ennaltaehkäisemiseksi.
2. Patenttivaatimuksen 1 mukainen käyttö farmaseuttisen koostumuksen valmistamiseksi paikallista käyttöä varten. Patentkav
2. Användning enligt patentkravet 1 for framställning av en farmaceutisk komposition för lokalt bruk.
FI20002229A 2000-10-09 2000-10-09 Förfarande för att behandla ryggsjukdom FI115032B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI20002229A FI115032B (sv) 2000-10-09 2000-10-09 Förfarande för att behandla ryggsjukdom

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20002229 2000-10-09
FI20002229A FI115032B (sv) 2000-10-09 2000-10-09 Förfarande för att behandla ryggsjukdom

Publications (3)

Publication Number Publication Date
FI20002229A0 FI20002229A0 (sv) 2000-10-09
FI20002229A FI20002229A (sv) 2002-04-10
FI115032B true FI115032B (sv) 2005-02-28

Family

ID=8559263

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20002229A FI115032B (sv) 2000-10-09 2000-10-09 Förfarande för att behandla ryggsjukdom

Country Status (1)

Country Link
FI (1) FI115032B (sv)

Also Published As

Publication number Publication date
FI20002229A (sv) 2002-04-10
FI20002229A0 (sv) 2000-10-09

Similar Documents

Publication Publication Date Title
Dworkin et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations
Simpson et al. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain
Steiner et al. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study
KR101263225B1 (ko) 설사－우세형 및 교대형 과민성 장 증후군의 치료를 위한 카파－아편제 작용제
Burton et al. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations
McElroy et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
Popp et al. Intravenous antiarrhythmic doses of lidocaine increase the survival rate of CA1 neurons and improve cognitive outcome after transient global cerebral ischemia in rats
JP2023514559A (ja) 頭痛障害の幻覚剤処置
BR112020005998A2 (pt) uso de formulação de fenfluramina na redução em número e em frequências de crises convulsivas em populações de pacientes
Saberi et al. Ondansetron or promethazine: which one is better for the treatment of acute peripheral vertigo?
JP2023181440A (ja) Ｓｕｒ１－ｔｒｐｍ４チャネル阻害剤による医療処置方法
Dorf et al. Lidocaine-induced altered mental status and seizure after hematoma block
Morrell Antiepileptic medications for the treatment of epilepsy
FI115032B (sv) Förfarande för att behandla ryggsjukdom
WO2013103867A1 (en) Benzenesulfonamide derivative for use in the treatment of diabetic neuropathy
Shini A review of diazepam and its use in the horse
Gün et al. Use of intravenous lipid emulsion therapy in a case of atomoxetine (Strattera®) toxicity
JPH10251146A (ja) 糖尿病性神経障害の治療方法
González-Vílchez et al. Conversion from immediate-release tacrolimus to prolonged-release tacrolimus in stable heart transplant patients: a retrospective study
Babu et al. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers
Lewandowska et al. Therapeutic Potential of Dronabinol: A Systematic Review of Human Trials
Soumoff et al. Delirium following topical application of compounded creams containing multiple analgesic medications in geriatric patients: two new cases
Turedi et al. First time, low dose citalopram use-related serotonin syndrome
WO2009108785A2 (en) Method for treating schizophrenia
San Francisco Late-Breaking Abstracts

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115032

Country of ref document: FI

MA Patent expired